Direct Vasodilators and Sympatholytic Agents

    Meghan N. McComb, James Y. Chao, Tien M. H. Ng
    TLDR Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.
    The document reviewed the use of direct vasodilators and sympatholytic agents, such as hydralazine and clonidine, in managing cardiovascular diseases, particularly hypertension and heart failure. Despite reduced use due to side effects and newer drug classes, these agents showed comparable blood pressure-lowering effects. Hydralazine had niche applications, including refractory hypertension, renal dysfunction, and pregnancy-induced hypertension, and was beneficial in combination with isosorbide dinitrate for systolic heart failure in African American patients. Minoxidil was effective for severe hypertension and renal dysfunction but had side effects like tachycardia and hypertrichosis. Alpha-1 adrenergic blockers (prazosin, terazosin, doxazosin) and alpha-2 adrenergic agonists (clonidine, methyldopa) were also discussed for their efficacy and side effects. The document emphasized the importance of these drugs in combination therapies, especially for patients with renal impairment, despite limited robust clinical trial data.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 1000+ results